Europe's luxury sector is showing signs of revival — but China weakness and tariff threats loom
The sector had an upbeat earnings season. But continued weakness in China and U.S. tariffs could leave even the most ...
Zydus Lifesciences, Granules, Glenmark: Nifty Pharma up despite weak market
Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...
Indian stock market lags behind its global peers in 2025. Is the worst yet to come?
The Indian stock market has seen a dramatic downturn in 2025, with major indices losing substantial value. Investors are ...